$APVO
Aptevo Therapeutics Inc.

2020 Q1 Form 10-K Financial Statement

#000156459020012791 Filed on March 25, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q4 2019
Revenue $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Cost Of Revenue $19.93M
YoY Change 77.76%
Gross Profit -$19.93M
YoY Change -268.16%
Gross Profit Margin
Selling, General & Admin $3.620M $3.530M $25.34M
YoY Change -50.61% -46.35% -9.94%
% of Gross Profit
Research & Development $4.010M $4.410M $24.76M
YoY Change -44.96% -50.45% -30.02%
% of Gross Profit
Depreciation & Amortization $460.0K $540.0K $2.235M
YoY Change -21.1% -11.48% -6.49%
% of Gross Profit
Operating Expenses $7.622M $7.940M $50.10M
YoY Change -31.71% -48.71% -21.13%
Operating Profit -$70.03M
YoY Change 35.54%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$275.0K -$460.0K -$2.100M
YoY Change -52.42% 6.98% 3.75%
Pretax Income -$10.00M -$8.400M -$43.06M
YoY Change -14.82% -40.09% -19.79%
Income Tax $1.000M
% Of Pretax Income
Net Earnings $2.897M -$8.170M -$40.45M
YoY Change -124.11% -42.18% -24.66%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $886.9K -$2.522M -$13.85M
COMMON SHARES
Basic Shares Outstanding 45.28M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2019 Q4 2019
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.30M $12.40M $12.40M
YoY Change -66.76% -59.48% -59.48%
Cash & Equivalents $14.79M $12.45M $12.40M
Short-Term Investments
Other Short-Term Assets $1.224M $160.0K $4.400M
YoY Change -88.34% -96.14% -60.0%
Inventory $6.139M $6.100M
Prepaid Expenses $1.343M $1.078M
Receivables $7.022M $7.000M
Other Receivables $0.00 $0.00
Total Short-Term Assets $14.83M $30.00M $30.00M
YoY Change -74.26% -38.39% -38.4%
LONG-TERM ASSETS
Property, Plant & Equipment $7.100M $3.946M $7.700M
YoY Change 42.63% -24.14% 48.08%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.300M $757.0K $11.30M
YoY Change 164.21% -16.35% 34.52%
Total Long-Term Assets $10.38M $23.41M $23.40M
YoY Change -55.28% 24.5% 24.47%
TOTAL ASSETS
Total Short-Term Assets $14.83M $30.00M $30.00M
Total Long-Term Assets $10.38M $23.41M $23.40M
Total Assets $25.20M $53.41M $53.40M
YoY Change -68.81% -20.87% -20.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.000M $13.00M $13.00M
YoY Change -54.72% 11.39% 11.11%
Accrued Expenses $1.700M $4.500M $4.500M
YoY Change -72.13% 15.38% 15.38%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $19.86M $19.90M
YoY Change
Total Short-Term Liabilities $6.993M $38.24M $38.20M
YoY Change -61.79% 117.14% 117.05%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Other Long-Term Liabilities $3.100M $3.300M $3.300M
YoY Change -22.5% 1550.0% 1550.0%
Total Long-Term Liabilities $3.100M $3.300M $3.300M
YoY Change -86.75% -83.06% -83.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.993M $38.24M $38.20M
Total Long-Term Liabilities $3.100M $3.300M $3.300M
Total Liabilities $10.10M $41.57M $41.60M
YoY Change -75.78% 12.07% 12.13%
SHAREHOLDERS EQUITY
Retained Earnings -$167.9M
YoY Change 31.75%
Common Stock $179.7M
YoY Change 13.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $15.15M $11.84M $11.80M
YoY Change
Total Liabilities & Shareholders Equity $25.20M $53.41M $53.40M
YoY Change -68.81% -20.87% -20.89%

Cashflow Statement

Concept 2020 Q1 2019 Q4 2019
OPERATING ACTIVITIES
Net Income $2.897M -$8.170M -$40.45M
YoY Change -124.11% -42.18% -24.66%
Depreciation, Depletion And Amortization $460.0K $540.0K $2.235M
YoY Change -21.1% -11.48% -6.49%
Cash From Operating Activities -$11.18M -$5.100M -$42.38M
YoY Change -19.28% -30.04% -17.58%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $153.0K
YoY Change -100.0% -100.0% -84.32%
Acquisitions
YoY Change
Other Investing Activities $28.12M $0.00 $4.250M
YoY Change -100.0% -94.24%
Cash From Investing Activities $28.12M $0.00 $4.097M
YoY Change -18479.08% -100.0% -94.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $22.10M
YoY Change
Cash From Financing Activities -22.10M -130.0K 20.15M
YoY Change -208.5% -425.0% -2660.23%
NET CHANGE
Cash From Operating Activities -11.18M -5.100M -42.38M
Cash From Investing Activities 28.12M 0.000 4.097M
Cash From Financing Activities -22.10M -130.0K 20.15M
Net Change In Cash -5.159M -5.230M -18.14M
YoY Change -180.91% -392.18% -188.1%
FREE CASH FLOW
Cash From Operating Activities -$11.18M -$5.100M -$42.38M
Capital Expenditures $0.00 $0.00 $153.0K
Free Cash Flow -$11.18M -$5.100M -$42.54M
YoY Change -20.16% -29.56% -18.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
45279244
CY2019Q2 dei Entity Public Float
EntityPublicFloat
36600000
CY2019 dei Entity File Number
EntityFileNumber
001-37746
CY2019 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2019 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-1567056
CY2019 dei Entity Address Address Line1
EntityAddressAddressLine1
2401 4th Avenue
CY2019 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1050
CY2019 dei Entity Address City Or Town
EntityAddressCityOrTown
Seattle
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2019 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98121
CY2019 dei City Area Code
CityAreaCode
206
CY2019 dei Local Phone Number
LocalPhoneNumber
838-0500
CY2019 dei Document Annual Report
DocumentAnnualReport
true
CY2019 dei Document Transition Report
DocumentTransitionReport
false
CY2019 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
us-gaap:ProductMember
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4420000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12448000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7022000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5220000
CY2019Q4 us-gaap Inventory Net
InventoryNet
6139000
CY2018Q4 us-gaap Inventory Net
InventoryNet
1785000
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6907000
CY2018Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
7448000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5202000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5250000
CY2018Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
11671000
CY2019Q4 apvo Sales Rebates And Discounts Payable Current
SalesRebatesAndDiscountsPayableCurrent
726000
CY2018Q4 apvo Sales Rebates And Discounts Payable Current
SalesRebatesAndDiscountsPayableCurrent
1245000
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
19278000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
200000
CY2019 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3747000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
905000
CY2018Q4 us-gaap Assets
Assets
67494000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3898000
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
19863000
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
796000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
17610000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2018 apvo Non Cash Interest Expense And Other
NonCashInterestExpenseAndOther
988000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-787000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
20588000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17495000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19946000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3327000
CY2018Q4 us-gaap Liabilities
Liabilities
37088000
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
23000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
157791000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-127408000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
30406000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
67494000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22808416
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22808416
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23067000
CY2018 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
us-gaap:ProductMember
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19927000
CY2018 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
us-gaap:ProductMember
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
25336000
CY2019 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
4250000
CY2018 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-2.39
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-40448000
CY2019 us-gaap Profit Loss
ProfitLoss
-40448000
CY2018 us-gaap Profit Loss
ProfitLoss
-53689000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
2140000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2390000
CY2019 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
4250000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1802000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3079000
CY2018 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
16535000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4097000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
72797000
CY2019 apvo Proceeds From Long Term Debt Net Of Issuance Costs And Modification Fees
ProceedsFromLongTermDebtNetOfIssuanceCostsAndModificationFees
-137000
CY2019 apvo Proceeds From Issuance Or Exercise Of Common Stock Warrants And Pre Funded Warrants
ProceedsFromIssuanceOrExerciseOfCommonStockWarrantsAndPreFundedWarrants
20344000
CY2018 apvo Proceeds From Issuance Or Exercise Of Common Stock Warrants And Pre Funded Warrants
ProceedsFromIssuanceOrExerciseOfCommonStockWarrantsAndPreFundedWarrants
623000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4354000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
757000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3614000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1315000
CY2019 apvo Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
945000
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
938000
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1279000
CY2019 apvo Increase Decrease In Long Term Operating Lease Liability
IncreaseDecreaseInLongTermOperatingLeaseLiability
1039000
CY2018 apvo Increase Decrease In Long Term Operating Lease Liability
IncreaseDecreaseInLongTermOperatingLeaseLiability
-621000
CY2019 apvo Increase Decrease In Sales Rebates And Discounts
IncreaseDecreaseInSalesRebatesAndDiscounts
519000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-42383000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-51422000
CY2018 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
90243000
CY2019 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
4250000
CY2018 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
65000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
153000
CY2019 apvo Payment Of Tax Liability For Vested Equity Awards
PaymentOfTaxLiabilityForVestedEquityAwards
58000
CY2018 apvo Payment Of Tax Liability For Vested Equity Awards
PaymentOfTaxLiabilityForVestedEquityAwards
808000
CY2018 apvo Fees Paid To Lender In Connection With Amendment Of Debt Agreement
FeesPaidToLenderInConnectionWithAmendmentOfDebtAgreement
602000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20149000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-18137000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
38083000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
82035000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
623000
CY2018 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-808000
CY2019 apvo Stock Issued During Period Value Common Stock Pre Funded Warrants And Warrants Net
StockIssuedDuringPeriodValueCommonStockPreFundedWarrantsAndWarrantsNet
20344000
CY2019 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-58000
CY2019 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentrations of Credit Risk</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject Aptevo to concentrations of credit risk consist primarily of cash and cash equivalents, certain investments and accounts receivable. Aptevo places its cash and cash equivalents with high quality financial institutions and may maintain cash balances in excess of insured limits. Management believes that the financial risks associated with its cash and cash equivalents are minimal.</p>
CY2019Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
491000
CY2018Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
194000
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1958000
CY2019 apvo Number Of Revenue Generating Product
NumberOfRevenueGeneratingProduct
1
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
5000000
CY2019 apvo Reduction In Research And Development Expense
ReductionInResearchAndDevelopmentExpense
1400000
CY2018 apvo Reduction In Research And Development Expense
ReductionInResearchAndDevelopmentExpense
600000
CY2019Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2019Q4 us-gaap Cash
Cash
4954000
CY2018Q4 us-gaap Cash
Cash
6588000
CY2019Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
7494000
CY2018Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
24047000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19946000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38083000
CY2017Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
10000000
CY2019Q1 apvo Operating Lease Property Number Of Lab Equipment
OperatingLeasePropertyNumberOfLabEquipment
1
CY2019Q1 apvo Operating Lease Property Number Of Copiers
OperatingLeasePropertyNumberOfCopiers
4
CY2019Q1 apvo Finance Lease Number Of Equipment
FinanceLeaseNumberOfEquipment
1
CY2019 apvo Lessee Finance Lease Remaining Term Of Contract
LesseeFinanceLeaseRemainingTermOfContract
P8M
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
1526000
CY2019 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
6000
CY2019 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
2000
CY2019 us-gaap Lease Cost
LeaseCost
1534000
CY2018Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
916000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3690000
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
675000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13870000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13900000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9924000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8698000
CY2019 us-gaap Depreciation
Depreciation
1400000
CY2018 us-gaap Depreciation
Depreciation
1600000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
800000
CY2019 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P63M
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
830000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
830000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
830000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
830000
CY2019Q4 apvo Finite Lived Intangible Assets Amortization Expense Year Four And After
FiniteLivedIntangibleAssetsAmortizationExpenseYearFourAndAfter
1100000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3747000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
1714000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1480000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1387000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1294000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1399000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5560000
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1306000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4254000
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y3M18D
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1455
CY2019Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
19850000
CY2019Q1 apvo Number Of Warrants Issued
NumberOfWarrantsIssued
19850000
CY2019Q1 apvo Number Of Common Stock Shares To Be Issued Exercise Of Prefunded Warrants
NumberOfCommonStockSharesToBeIssuedExerciseOfPrefundedWarrants
2150000
CY2019 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
200000
CY2019Q1 apvo Pre Funded Warrants And Rights Outstanding Term
PreFundedWarrantsAndRightsOutstandingTerm
P10Y
CY2019Q1 apvo Prefunded Warrant Expiration Date
PrefundedWarrantExpirationDate
2029-03-11
CY2019 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.06
CY2019 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
400000
CY2018 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
500000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-44698000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
3000
CY2019Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
453000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
40767000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
39895000
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
872000
CY2019Q4 apvo Deferred Tax Liability Right Of Use Assets
DeferredTaxLiabilityRightOfUseAssets
874000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
874000
CY2019Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
2000
CY2019Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
93400000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.018
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.025
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.237
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.245
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.016
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.004
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.007
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.002
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.000
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.008
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000

Files In Submission

Name View Source Status
0001564590-20-012791-index-headers.html Edgar Link pending
0001564590-20-012791-index.html Edgar Link pending
0001564590-20-012791.txt Edgar Link pending
0001564590-20-012791-xbrl.zip Edgar Link pending
apvo-10k_20191231.htm Edgar Link pending
apvo-20191231.xml Edgar Link completed
apvo-20191231.xsd Edgar Link pending
apvo-20191231_cal.xml Edgar Link unprocessable
apvo-20191231_def.xml Edgar Link unprocessable
apvo-20191231_lab.xml Edgar Link unprocessable
apvo-20191231_pre.xml Edgar Link unprocessable
apvo-ex211_50.htm Edgar Link pending
apvo-ex231_51.htm Edgar Link pending
apvo-ex311_49.htm Edgar Link pending
apvo-ex312_52.htm Edgar Link pending
apvo-ex321_54.htm Edgar Link pending
apvo-ex322_53.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2mzwu31cuci000001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending